Abiopharma

Yunji to Report First Half 2026 Financial Results on August 20, 2026

Monro, Inc. Declares Quarterly Cash Dividend

MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury

Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission

Rio2 Reports Q2 2026 Financial and Operating Results and Webinar

BTQ Technologies Signs MOU with ITCENGLOBAL, a KRW 8.9 Trillion Korean IT Group, to Advance Post-Quantum Security Across Koreas Financial, Public-Sector, and Enterprise Infrastructure

Intuitive Machines Reports Second Quarter 2026 Financial Results; Continues Record Backlog Expansion With Quarter-end Backlog of $1.8 Billion

NEUPATH HEALTH REPORTS SECOND QUARTER 2026 RESULTS

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

Ascendis Pharma Reports Second Quarter 2026 Financial Results